KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Petmed Express (PETS) over the last 17 years, with Q4 2025 value amounting to -$1000.0.

  • Petmed Express' Gains from Investment Securities fell 11250.0% to -$1000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $288000.0, marking a year-over-year decrease of 4866.31%. This contributed to the annual value of $525000.0 for FY2025, which is 30384.62% up from last year.
  • Petmed Express' Gains from Investment Securities amounted to -$1000.0 in Q4 2025, which was down 11250.0% from $209000.0 recorded in Q3 2025.
  • In the past 5 years, Petmed Express' Gains from Investment Securities registered a high of $1.3 million during Q4 2022, and its lowest value of -$1000.0 during Q4 2025.
  • For the 5-year period, Petmed Express' Gains from Investment Securities averaged around $205756.2, with its median value being $51000.0 (2025).
  • As far as peak fluctuations go, Petmed Express' Gains from Investment Securities surged by 863333.33% in 2022, and later tumbled by 11250.0% in 2025.
  • Quarter analysis of 5 years shows Petmed Express' Gains from Investment Securities stood at $15000.0 in 2021, then surged by 8633.33% to $1.3 million in 2022, then tumbled by 96.72% to $43000.0 in 2023, then tumbled by 81.4% to $8000.0 in 2024, then tumbled by 112.5% to -$1000.0 in 2025.
  • Its Gains from Investment Securities stands at -$1000.0 for Q4 2025, versus $209000.0 for Q3 2025 and $29000.0 for Q2 2025.